- Companies
- New England Patriots
New England Patriots Acquisition, Valuation, Funding & Investors
New England Patriots was acquired by Robert Kraft for $172M in January 1994.
New England Patriots acquisition price
$172M
Acquired by Robert Kraft · Jan 1994
New England Patriots revenue
$762M
Undisclosed stage · Sep 2025
Cumulative funding New England Patriots raised
$720M
across 1 funding round
Key investors in New England Patriots
Sixth Street
C. Dean Metropoulos
About New England Patriots
The New England Patriots are a professional American football team based in Foxborough, Massachusetts, that competes in the AFC East division of the National Football League. The franchise was founded in 1959 by Billy Sullivan as the Boston Patriots, a charter member of the American Football League, joined the NFL in the 1970 merger and took its current name in 1971 on moving to Foxboro Stadium. It has played at Gillette Stadium since 2002. Owned successively by Sullivan, Victor Kiam and James Orthwein, the team has belonged to Robert Kraft since 1994 and is held by his family's Kraft Group, with Kraft as chairman and chief executive. Under head coach Bill Belichick and quarterback Tom Brady, the Patriots won six Super Bowls between the 2001 and 2018 seasons, tying the Pittsburgh Steelers for the most in NFL history. The club earns revenue from its share of NFL national media and sponsorship income, ticket and premium seating sales, local sponsorship and merchandise. In September 2025 Kraft agreed to sell minority stakes of 5% to investor Dean Metropoulos and 3% to Sixth Street at a valuation of about $9 billion, with the family keeping more than 90%.
Founded
1959
HQ
Website
Status
Acquired
Customer focus
B2C
Revenue model
Product sales
Revenue
$762M (Sep 2025)
Valuation
$9B (Sep 2025)
Sectors
New England Patriots Acquisition
New England Patriots was acquired by Robert Kraft for $172M on 21 January 1994.
Before the acquisition New England Patriots had raised $720M across 1 funding round.
Robert Kraft bought the New England Patriots from James Orthwein in January 1994 for $172 million, then a record price for an NFL franchise; he completed the purchase on 21 January 1994. Orthwein, a St. Louis native who had bought the team from Victor Kiam in 1992, wanted to move it to his home city, but Kraft owned Foxboro Stadium, and its operating covenant required the Patriots to play there until 2002. Orthwein offered Kraft $75 million to buy out the lease; Kraft declined and made his own bid for the team, outmanoeuvring rival bidders including Stan Kroenke, who had offered $200 million with the intention of moving the club to St. Louis. The purchase kept the franchise in New England. Under Kraft's ownership the Patriots moved into the privately financed Gillette Stadium in 2002 and won six Super Bowls. Kraft is chairman of The Kraft Group, a Boston-area holding company with paper and packaging, sports and real estate businesses.
| Acquirer | Date | Type | Price |
|---|---|---|---|
| 21 Jan 1994 | Strategic M&A | $172M |
Sources: boston.com, en.wikipedia.org
New England Patriots Valuation
New England Patriots is currently valued at $9B, based on its undisclosed-stage round in September 2025. Read the announcement ↗
The $720M round was led by C. Dean Metropoulos and Sixth Street.
New England Patriots valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Sep 2025 | Undisclosed stage | $9B | 11.8x |
New England Patriots Revenue
New England Patriots' latest recorded revenue is $762M, as of its undisclosed-stage round in September 2025. At a $9B valuation, that implies a 11.8x revenue multiple.
New England Patriots revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Sep 2025 | $762M | $9B | 11.8x | Undisclosed stage |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
New England Patriots Funding History
New England Patriots has raised a total of $720M across 1 funding round.
New England Patriots funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Sep 2025 | Undisclosed stage | C. Dean Metropoulos (lead); Sixth Street (lead) | $720M | $9B | The New England Patriots agreed to sell an 8% stake in the NFL franchise in September 2025, with billionaire C. Dean Metropoulos purchasing 5% and private equity firm Sixth Street acquiring 3%, at a franchise valuation exceeding US$9 billion. This marks the second-highest NFL team valuation, behind the New York Giants at over $10 billion, and represents Sixth Street's first NFL investment following league policy changes. The Kraft family, who bought the team for $172 million in 1994, retains over 90% ownership, with proceeds intended for reinvestment into the franchise; the deal excludes the New England Revolution MLS team and awaits NFL owners' approval in October 2025. CNBC estimated the Patriots' worth at $9.25 billion prior to the announcement, ranking it fifth among NFL franchises. |
Who has invested in New England Patriots?
2 investors have backed New England Patriots across its funding rounds, including Sixth Street and C. Dean Metropoulos.
Lead investors include C. Dean Metropoulos and Sixth Street.
New England Patriots Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 2 New England Patriots investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialInvestments by New England Patriots
New England Patriots has invested in 1 company to date.
Latest investment by New England Patriots was on June 8th 2015. New England Patriots invested in Spero Therapeutics in their $30M Series A round.
Latest Investments by New England Patriots
| Description | Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital. |
| HQ Country | |
| HQ City | Cambridge |
| Deal Date | 8 Jun 2015 |
| Round | Series A |
| Raised | $30M |
| Investors | GSK; SR One; Atlas Venture; Merck Global Health Innovation Fund; Lundbeckfonden Ventures; The Kraft Group; Partners Innovation Fund |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all New England Patriots investments and their VC round multiples. Start Free Trial | |
New England Patriots Competitors
New England Patriots competitors include listed companies like MSG Sports and TKO, and private ones like Suning Sports, Chicago Bears, Las Vegas Raiders and New York Giants.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $2.6B | - | ||
| Private | $629M | - | $8.9B | 14.1x | ||
| Private | $887M | $191M | $9.9B | 11.2x | ||
| Private | $707M | $181M | $10B | 14.6x | ||
| Publicly listed | $1.2B | $39M | $7.5B | 7.7x | ||
| Publicly listed | $4.7B | $1.3B | $14B | 4.1x |
New England Patriots Public Comps
New England Patriots is no longer listed, but its public comps include MSG Sports, TKO, Sportradar, Manchester United, Atlanta Braves Holdings, MSG Rangers, Cannae Holdings, Juventus FC, Ollamani and Rogers.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1.2B | $39M | 7.5x | 7.7x | 220.2x | 285.3x | |||
| $4.7B | $1.3B | 4.9x | 4.1x | 17.5x | 10.5x | |||
| $1.4B | $597M | 2.7x | 2.3x | 6.5x | 9.8x | |||
| $910M | $321M | 5.2x | 5.0x | 14.7x | 16.3x | |||
| $732M | $98M | 5.6x | 5.3x | 42.2x | 79.8x | |||
| $341M | ($24M) | 7.9x | 7.9x | (113.8x) | (106.3x) | |||
| $424M | ($162M) | 2.0x | 2.2x | (5.3x) | (16.8x) | |||
| $586M | $121M | 1.9x | 2.1x | 9.1x | 9.9x | |||
This data is available for Pro users. Sign up to see all New England Patriots competitors and their valuation data. Start Free Trial | ||||||||
Common questions about New England Patriots
| When was New England Patriots founded? | New England Patriots was founded in 1959. |
| Where is New England Patriots headquartered? | New England Patriots is headquartered in Foxborough, MA, United States. |
| Is New England Patriots publicly listed? | No, New England Patriots was acquired by Robert Kraft in January 1994. |
| Who acquired New England Patriots? | New England Patriots was acquired by Robert Kraft in January 1994. |
| How much was New England Patriots acquired for? | New England Patriots was acquired for $172M in January 1994. |
| What is New England Patriots' valuation? | New England Patriots was last valued at $9B in its undisclosed-stage round in September 2025. |
| How much funding has New England Patriots raised? | New England Patriots has raised $720M across 1 funding round. |
| What was New England Patriots' last funding round? | New England Patriots' last funding round was a $720M undisclosed-stage round in September 2025, led by C. Dean Metropoulos and Sixth Street. |
| Who are New England Patriots' investors? | New England Patriots' investors include C. Dean Metropoulos and Sixth Street. |
| What is New England Patriots' revenue? | New England Patriots' latest recorded revenue is $762M (September 2025). |
| What is New England Patriots' revenue multiple? | New England Patriots' latest valuation implies a 11.8x revenue multiple ($9B valuation on $762M of revenue). |
| Which companies are comparable to New England Patriots? | Companies comparable to New England Patriots include Suning Sports, Chicago Bears, Las Vegas Raiders, New York Giants, MSG Sports and TKO. |
| How many companies has New England Patriots invested in? | New England Patriots has invested in 1 company, including Spero Therapeutics. |
| What was New England Patriots' last investment? | In June 2015, New England Patriots invested in Spero Therapeutics' $30M Series A alongside GSK, SR One, Atlas Venture and 4 other investors. |
See companies similar to New England Patriots
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




